Romania Anti Aging Therapeutics Market Report 2022 to 2030

Romania Anti Aging Therapeutics Market Analysis

$ 3999

Romania anti-aging therapeutics market is projected to grow from $2 Mn in 2022 to $6 Mn in 2030 with a CAGR of 16.78% for the year 2022-2030. The growing economy in Romania and supportive government policies for increased R&D investments in anti-aging therapeutics in Romania are responsible for the growth of the market. The Romania anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the major players in the market include Leciva Slovakofarma, ICCF, and Mitobridge.

ID: IN10ROPH030 CATEGORY: Pharmaceuticals GEOGRAPHY: Romania AUTHOR: Parul Choudhary

Buy Now

Romania Anti-Aging Therapeutics Market Executive Summary

The Romania anti-aging therapeutics market size is at around $2 Mn in 2022 and is projected to reach $6 Mn in 2030, exhibiting a CAGR of 16.78% during the forecast period. The 2023 budget plan will be approved by the coalition administration in Romania with the intention of bringing the fiscal deficit down to 4.4% of GDP and using EU recovery funds to increase public investment. Due to the government's significant budget deficit, the Romanian government has stated that state spending on health care will be reduced by approximately $911.2 Mn. Hajdu Gabor, the minister of health, stated that as a result of the funding cut, the ministry will have to stop the majority of investments, decrease spending on hospitals, and eliminate all staff vacancies in the health service.

Age-related reductions in telomere length, a sign of cellular aging, have been linked to illnesses of old age. Environmental elements, such as dietary choices and way of life, have an impact on how quickly telomeres shorten, a process that telomerase can restore. It has been proposed that the activation of telomerase by natural molecules acts as an anti-aging modulator and may aid in the treatment of illnesses associated with aging. Since telomere shortening has been linked to cellular aging and telomerase-related gene mutations with several illnesses, telomerase activators are crucial for anti-aging and telomerase-dependent disease treatments.

Procaine, potassium metabisulphite, and disodium phosphate are all ingredients in Gerovital H3. Its complicated effects are a result of the product's action at the level of the central and autonomic nervous systems, as well as at the cellular level, where it stimulates the regeneration of tissues and enhances metabolic functions. It has also been demonstrated that the product acts in oxidation-reduction phenomena in the cell. In Romania, Gerovital H3-based anti-aging treatments are made available. Another product developed in Romania as a follow-up to Gerovital H3 is called Aslavital. It also includes vitamins and works well to prevent and treat the effects of aging.

Romania Anti Aging Therapeutics Market

Market Dynamics

Market Growth Drivers Analysis

Romanian customers are more inclined to spend money on anti-aging products and treatments as disposable income rises. The Romania anti-aging therapeutics market is expected to expand as a result of this tendency. The growth of the healthcare sector, including the market for anti-aging therapeutics, is actively encouraged by the Romanian government. In addition to tax breaks for businesses operating in the sector, this assistance also includes funding for research and development. The Romania anti-aging therapeutics market is anticipated to expand as a result of this assistance.

Market Restraints

Anti-aging products and therapies can be costly, putting them out of reach for many consumers. This might prevent the Romania anti-aging therapeutics market from expanding, especially among those with poor incomes. Numerous alternative medical treatments and goods, including herbal remedies and dietary supplements, are promoted as anti-aging solutions. These goods may contend with conventional anti-aging treatments and restrain market expansion.

Competitive Landscape

Key Players

Sunwave Pharma (ROU)
Regina Maria (ROU)
Baby Stem Cells (ROU)
Leciva Slovakofarma (ROU)
ICCF (ROU)
Mitobridge
Navitor Pharmaceuticals
NeuroTrack
Nuchido
NuSirt
OneSkin Technologies
PharmatrophiX
Proteostasis Therapeutics
Retrotope

Healthcare Policies and Regulatory Landscape

The National Agency for Medicines and Medical Devices (ANMDM) is the regulatory authority in charge of monitoring the authorization and control of anti-aging medications in Romania. ANMDM is a governmental organization that reports to the Ministry of Health in Romania. Its main duty is to guarantee that all medications and medical equipment sold on the Romanian market are both efficient and secure for patients to use. Companies must present a record of data to ANMDM that demonstrates the product's safety, effectiveness, and quality in order to get approval for an anti-aging drug. After reviewing the file, the ANMDM will decide whether or not to authorize the drug for use in Romania. The ANMDM has the power to take action if it learns of any safety concerns or problems and also keeps an eye on the safety of medicines that are already on the market. If a product is deemed unsafe, it may be necessary for businesses to alter the labelling on it or even remove it from the market.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Anti-Aging Therapeutics Market Segmentation

By Product (Revenue, USD Billion):

Anti-Wrinkle
Hair Color
Ultraviolet (UV) Absorption
Anti-Stretch Mark
Others

By Treatment (Revenue, USD Billion):

Hair Restoration
Anti-Pigmentation
Adult Acne Therapy
Breast Augmentation
Liposuction
Chemical Peel
Others

By Target Group (Revenue, USD Billion):

Male
Female

By Type of Aging (Revenue, USD Billion):

Cellular Aging
Immune Aging
Metabolic Aging
Others

By Type of Molecules (Revenue, USD Billion):

Biologics
Small Molecules

By Mechanism of Action (Revenue, USD Billion):

Senolytic
Cell Regeneration
mTOR inhibitor/Modulator
AMP-kinase/AMP Activator
Mitochondria Inhibitor/Modulator
Others

By Ingredient (Revenue, USD Billion):

Retinoid
Hyaluronic Acid
Alpha Hydroxy Acid
Others

By Distribution Channel (Revenue, USD Billion):

Pharmacies
Stores
Online Stores

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.